Literature DB >> 15326249

Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.

Margaret Lane1, John McBride, John Archer.   

Abstract

The authors describe the clinical course of Cryptococcus neoformans variety gattii infection in a young immunocompetent man who had a late deterioration characterized by headaches, subarachnoid inflammation, hydrocephalus, and stroke that reproducibly responded to steroids. These findings, in combination with declining markers of CSF infection, are consistent with the late deterioration being caused by sterile arachnoiditis rather than ongoing infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326249     DOI: 10.1212/01.wnl.0000134677.29120.62

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Cryptococcus gattii as an important fungal pathogen of western North America.

Authors:  Kieren A Marr
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

Review 2.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  FLAIR vascular hyperintensity preceding stroke in cryptococcal meningitis.

Authors:  Nerses Sanossian; Ron A Shatzmiller; Christina Djabiras; David S Liebeskind
Journal:  J Neuroimaging       Date:  2011-03-16       Impact factor: 2.486

4.  The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues.

Authors:  Edmond J Byrnes; Kieren A Marr
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

5.  Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia.

Authors:  Eleni Galanis; Linda Hoang; Pamela Kibsey; Muhammad Morshed; Peter Phillips
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 6.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

7.  Cryptococcus gattii infections in multiple states outside the US Pacific Northwest.

Authors:  Julie R Harris; Shawn R Lockhart; Gail Sondermeyer; Duc J Vugia; Matthew B Crist; Melissa Tobin D'Angelo; Brenda Sellers; Carlos Franco-Paredes; Monear Makvandi; Chad Smelser; John Greene; Danielle Stanek; Kimberly Signs; Randall J Nett; Tom Chiller; Benjamin J Park
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

8.  Cryptococcus neoformans meningitis in a diabetic patient--the perils of an overzealous immune response: a case report.

Authors:  Anurag Kushawaha; Neville Mobarakai; Nirupama Parikh; Alex Beylinson
Journal:  Cases J       Date:  2009-11-19

9.  Clinical Aspects of Immune Damage in Cryptococcosis.

Authors:  Seher Anjum; Peter R Williamson
Journal:  Curr Fungal Infect Rep       Date:  2019-07-22

10.  CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.

Authors:  Jeremy Day; Darma Imran; Ahmed Rizal Ganiem; Natriana Tjahjani; Retno Wahyuningsih; Robiatul Adawiyah; David Dance; Mayfong Mayxay; Paul Newton; Rattanaphone Phetsouvanh; Sayaphet Rattanavong; Adrienne K Chan; Robert Heyderman; Joep J van Oosterhout; Wirongrong Chierakul; Nick Day; Anatoli Kamali; Freddie Kibengo; Eugene Ruzagira; Alastair Gray; David G Lalloo; Justin Beardsley; Tran Quang Binh; Tran Thi Hong Chau; Nguyen Van Vinh Chau; Ngo Thi Kim Cuc; Jeremy Farrar; Tran Tinh Hien; Nguyen Van Kinh; Laura Merson; Lan Phuong; Loc Truong Tho; Pham Thanh Thuy; Guy Thwaites; Heiman Wertheim; Marcel Wolbers
Journal:  Trials       Date:  2014-11-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.